SEARCH
Quotes News NAV
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Aptus Pharma Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544529 INE15XJ01010 29.1342566 Not Listed 0 105.47 0 0 10
     ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
INCOME :   
Sales Turnover 24.5617.8613.90
Excise Duty0.000.000.00
Net Sales24.5617.8613.90
Other Income 0.080.030.00
Stock Adjustments 3.631.130.90
Total Income28.2719.0214.80
EXPENDITURE :   
Raw Materials 12.677.955.67
Power & Fuel Cost0.000.010.00
Employee Cost 3.472.311.57
Other Manufacturing Expenses 2.032.773.28
Selling & Administrative Expenses 4.944.233.41
Miscellaneous Expenses 0.230.170.25
Less : Pre-operative Expenses Capitalised 0.000.000.00
Total Expenditure23.3417.4314.19
Operating Profit4.931.570.62
Interest 0.470.240.14
Gross Profit4.461.330.48
Depreciation0.270.210.18
Profit Before Tax4.191.120.30
Tax1.110.340.12
Fringe Benefit tax0.000.000.00
Deferred Tax-0.02-0.02-0.02
Reported Net Profit3.100.800.19
Extraordinary Items 0.000.000.00
Adjusted Net Profit3.100.800.19
Adjustment below Net Profit -3.050.00-0.08
P & L Balance brought forward1.120.320.20
Statutory Appropriations0.000.000.00
Appropriations 0.000.000.00
P & L Balance carried down1.171.120.32
Dividend0.000.000.00
Preference Dividend0.000.000.00
Equity Dividend %0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Earnings Per Share-Unit Curr6.2026.606.48
Earnings Per Share(Adj)-Unit Curr6.2026.606.48
Book Value-Unit Curr13.9358.8832.28
Book Value(Adj)-Unit Curr13.9358.8832.28